Learn more about the use of mHealth technology
in the mental health care
Monsenso provides medication adherence and behavioural monitoring components in H2020 Funded R-LiNK Study
Monsenso is participating in R-LiNK, the major new study for developing a more complete understanding of the reactions and effects of taking lithium. Monsenso is now involved in more than ten pan European and domestic research projects in the mental health & affective disorders field.
Big data can transform the mental health and life science industry. CPO Mads Frost writes a guest blog about how Monsenso’s mHealth solution offers new ways to inform treatment.
Mhealth can improve health outcomes by helping clinicians collect, view, and analyse patient information more efficiently.
Lack of budget and aversion to technology can make mHealth seem like an undesirable choice. We explored how our mHealth solution can help debunk these myths and avoid these obstacles.
Electronic and interactive monitoring systems can improve communication between clinicians and patients during the psychiatric medication switching process.
mHealth provides the opportunity to offer scalable and cost-effective mental healthcare. One of the greatest challenges the healthcare systems face is the long-term care of individuals with severe mental disorders. Fortunately, some of these issues can be partially solved with the use of mHealth technology.
Pharma can benefit from mHealth solutions by using them in clinical trials and by offering them to HCPs as part of a comprehensive treatment solution.
The number of patients monitored remotely will reach 50.2 million worldwide by 20121, according to Swedish Report
According to a new report by a research firm in Sweden, there were 7.1 million patients monitored remotely worldwide in 2016, which is an increase of 44%. The report also forecasts that the number will grow to 50.2 million by 2021.
Using mHealth solutions for clinical trials as data-collection tools, can potentially revolutionise clinical research. Wearable devices and mobile health solutions can offer pharmaceutical companies access to additional patient data to provide a more comprehensive overview of safety and efficacy.
Health apps are application programmes that offer health-related services for smartphones, tablet PCs and other communication devices.  On the other hand, mHealth refers to mobile-based or mobile-enhanced solutions that deliver health. Mobile devices offer the opportunity to improve health outcomes through the delivery of innovative medical and health services with information and communication technologies to the farthest reaches of the globe.